Your browser doesn't support javascript.
loading
TGF-ß-induced lncRNA TBUR1 promotes EMT and metastasis in lung adenocarcinoma via hnRNPC-mediated GRB2 mRNA stabilization.
Huang, Lijie; Liu, Xiaoxu; Chen, Qiuying; Yang, Jingyu; Zhang, Dongdong; Zhao, Yabing; Xu, Lele; Li, Zhangfu; Liu, Xinyuan; Shao, Shujuan; Li, Dan; Song, Yongmei; Liu, Xuefeng; Zhan, Qimin.
Afiliación
  • Huang L; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China
  • Liu X; Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
  • Chen Q; Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
  • Yang J; Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
  • Zhang D; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Key Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sci
  • Zhao Y; Liaoning Key Laboratory of Proteomics, Dalian Medical University, Dalian 116044, China.
  • Xu L; Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
  • Li Z; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Liu X; Liaoning Key Laboratory of Proteomics, Dalian Medical University, Dalian 116044, China.
  • Shao S; Liaoning Key Laboratory of Proteomics, Dalian Medical University, Dalian 116044, China.
  • Li D; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Song Y; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Liu X; Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China. Electronic address: ixuee@sina.com.
  • Zhan Q; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Soochow University Cancer institute, Suzhou 215000, China; Key Laboratory of C
Cancer Lett ; : 217153, 2024 Aug 03.
Article en En | MEDLINE | ID: mdl-39102940
ABSTRACT
The transforming growth factor-ß (TGF-ß) signaling pathway is pivotal in inducing epithelial-mesenchymal transition (EMT) and promoting cancer metastasis. Long non-coding RNAs (lncRNAs) have emerged as significant players in these processes, yet their precise mechanisms remain elusive. Here, we demonstrate that TGF-ß-upregulated lncRNA 1 (TBUR1) is significantly activated by TGF-ß via Smad3/4 signaling in lung adenocarcinoma (LUAD) cells. Functionally, TBUR1 triggers EMT, enhances LUAD cell migration and invasion in vitro, and promotes metastasis in nude mice. Mechanistically, TBUR1 interacts with heterogeneous nuclear ribonucleoproteins C (hnRNPC) to stabilize GRB2 mRNA in an m6A-dependent manner. Clinically, TBUR1 is upregulated in LUAD tissues and correlates with poor prognosis, highlighting its potential as a prognostic biomarker and therapeutic target for LUAD. Taken together, our findings underscore the crucial role of TBUR1 in mediating TGF-ß-induced EMT and metastasis in LUAD, providing insights for future therapeutic interventions.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancer Lett Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancer Lett Año: 2024 Tipo del documento: Article